Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: Systematic review and meta-analysis
Authors:
- Pippa ScottPSPippa Scott
- Anne W.S. RutjesARAnne W.S. Rutjes
- Lilian BermetzLBLilian Bermetz
- Nadège RobertNRNadège Robert
- Susana ScottSSSusana Scott
- Tania LourençoTLTania Lourenço
- Matthias EggerMEMatthias Egger
- Nicola LowNLNicola Low
- 1 December 2011
- Vol. 29 (52) , 9711-9721
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization scheduleVaccine, 2011
- Pneumococcal Nasopharyngeal Carriage following Reduced Doses of a 7-Valent Pneumococcal Conjugate Vaccine and a 23-Valent Pneumococcal Polysaccharide Vaccine BoosterClinical and Vaccine Immunology, 2010
- Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype ProjectPLOS Medicine, 2010
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesThe Lancet, 2009
- Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccineVaccine, 2009
- Efficacy of pneumococcal vaccination in adults: a meta-analysisCanadian Medical Association Journal, 2009
- Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological studyBMJ, 2008
- A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV InfectionNew England Journal of Medicine, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986